Latest Deep Track Capital, LP Stock Portfolio
Deep Track Capital, LP Performance:
2024 Q3: 0.41%YTD: 0.36%2023: -1.85%
Performance for 2024 Q3 is 0.41%, and YTD is 0.36%, and 2023 is -1.85%.
About Deep Track Capital, LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Deep Track Capital, LP reported an equity portfolio of $3.2 Billions as of 30 Sep, 2024.
The top stock holdings of Deep Track Capital, LP are , DVAX, GH. The fund has invested 6.3% of it's portfolio in ARGENX SE and 4.4% of portfolio in DYNAVAX TECHNOLOGIES CORP .
The fund managers got completely rid off AMGEN INC (AMGN), INSMED INC (INSM) and ALNYLAM PHARMACEUTICALS INC (ALNY) stocks. They significantly reduced their stock positions in TRAVERE THERAPEUTICS INC (TVTX), SCHOLAR ROCK HLDG CORP (SRRK) and KYMERA THERAPEUTICS INC (KYMR). Deep Track Capital, LP opened new stock positions in MBX BIOSCIENCES INC, AVIDITY BIOSCIENCES INC (RNA) and CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to EDGEWISE THERAPEUTICS INC (EWTX), KURA ONCOLOGY INC (KURA) and CYTOKINETICS INC (CYTK).
The top stock holdings of Deep Track Capital, LP are , DVAX, GH. The fund has invested 6.3% of it's portfolio in ARGENX SE and 4.4% of portfolio in DYNAVAX TECHNOLOGIES CORP .
The fund managers got completely rid off AMGEN INC (AMGN), INSMED INC (INSM) and ALNYLAM PHARMACEUTICALS INC (ALNY) stocks. They significantly reduced their stock positions in TRAVERE THERAPEUTICS INC (TVTX), SCHOLAR ROCK HLDG CORP (SRRK) and KYMERA THERAPEUTICS INC (KYMR). Deep Track Capital, LP opened new stock positions in MBX BIOSCIENCES INC, AVIDITY BIOSCIENCES INC (RNA) and CENTESSA PHARMACEUTICALS PLC (CNTA). The fund showed a lot of confidence in some stocks as they added substantially to EDGEWISE THERAPEUTICS INC (EWTX), KURA ONCOLOGY INC (KURA) and CYTOKINETICS INC (CYTK).
Deep Track Capital, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Deep Track Capital, LP made a return of 0.41% in the last quarter. In trailing 12 months, it's portfolio return was 12.41%.
New Buys
| Ticker | $ Bought |
|---|---|
| mbx biosciences inc | 78,431,900 |
| oruka therapeutics inc | 30,274,400 |
| avidity biosciences inc | 21,816,800 |
| centessa pharmaceuticals plc | 21,586,500 |
| bicara therapeutics inc | 20,295,800 |
| akero therapeutics inc | 19,789,900 |
| xencor inc | 16,088,000 |
| cybin inc | 13,601,600 |
New stocks bought by Deep Track Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| edgewise therapeutics inc | 490 |
| kura oncology inc | 410 |
| cytokinetics inc | 375 |
| vigil neuroscience inc | 160 |
| apellis pharmaceuticals inc | 76.03 |
| immunovant inc | 50.76 |
| guardant health inc | 33.35 |
| structure therapeutics inc | 28.47 |
Additions to existing portfolio by Deep Track Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| travere therapeutics inc | -92.78 |
| scholar rock hldg corp | -87.09 |
| kymera therapeutics inc | -59.98 |
| alto neuroscience inc | -57.07 |
| axsome therapeutics inc | -53.73 |
| relmada therapeutics inc | -45.35 |
| eliem therapeutics inc | -44.45 |
| spyre therapeutics inc | -43.07 |
Deep Track Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| cybin inc | -15,755,800 |
| insmed inc | -134,000,000 |
| hillevax inc | -26,500,100 |
| repare therapeutics inc | -2,984,060 |
| amgen inc | -179,659,000 |
| alnylam pharmaceuticals inc | -121,500,000 |
| praxis precision medicines i | -16,111,600 |
| agenus inc | -5,248,760 |
Deep Track Capital, LP got rid off the above stocks
Sector Distribution
Deep Track Capital, LP has about 81.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.1 |
| Others | 18.6 |
Market Cap. Distribution
Deep Track Capital, LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 43.5 |
| SMALL-CAP | 32.6 |
| UNALLOCATED | 20.3 |
| MICRO-CAP | 3.2 |
Stocks belong to which Index?
About 61.1% of the stocks held by Deep Track Capital, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 61.1 |
| Others | 38.9 |
Deep Track Capital, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Deep Track Capital, LP
Deep Track Capital, LP has 69 stocks in it's portfolio. About 41.1% of the portfolio is in top 10 stocks. FDMT proved to be the most loss making stock for the portfolio. VRDN was the most profitable stock for Deep Track Capital, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADGI | invivyd inc | 0.35 | 10,953,900 | 11,173,000 | unchanged | 0.00 | ||
| AGEN | agenus inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 0.93 | 1,000,000 | 29,410,000 | reduced | -43.07 | ||
| AKRO | akero therapeutics inc | 0.63 | 689,784 | 19,789,900 | new | |||
| ALEC | alector inc | 0.69 | 4,632,000 | 21,585,100 | unchanged | 0.00 | ||
| ALGS | aligos therapeutics inc | 0.07 | 244,110 | 2,113,990 | new | |||
| ALGS | aligos therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 3.11 | 3,500,000 | 97,965,000 | unchanged | 0.00 | ||
| ALLK | allakos inc | 0.10 | 5,000,000 | 3,266,000 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANIP | ani pharmaceuticals inc | 0.96 | 504,828 | 30,118,000 | added | 8.31 | ||
| APLS | apellis pharmaceuticals inc | 4.03 | 4,400,650 | 126,915,000 | added | 76.03 | ||
| AUTL | autolus therapeutics plc | 1.76 | 15,272,200 | 55,438,000 | unchanged | 0.00 | ||
| AVTX | avalo therapeutics inc | 0.29 | 967,000 | 9,186,500 | new | |||
| AXSM | axsome therapeutics inc | 2.44 | 857,219 | 77,038,300 | reduced | -53.73 | ||
| BCYC | bicycle therapeutics plc | 2.55 | 3,548,000 | 80,291,300 | added | 1.65 | ||
| CNTA | centessa pharmaceuticals plc | 0.69 | 1,350,000 | 21,586,500 | new | |||
| CNTX | context therapeutics inc | 0.46 | 7,419,360 | 14,541,900 | unchanged | 0.00 | ||
| COGT | cogent biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||